GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.

Leggio L, Hendershot CS, Farokhnia M, Fink-Jensen A, Klausen MK, Schacht JP, Simmons WK

Open source

DOI
10.1038/s41591-023-02634-8
Published
2023 Dec
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-023-02634-8,
  title = {GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.},
  author = {Leggio L and Hendershot CS and Farokhnia M and Fink-Jensen A and Klausen MK and Schacht JP and Simmons WK},
  year = {2023},
  journal = {Nature medicine},
  doi = {10.1038/s41591-023-02634-8},
  url = {https://doi.org/10.1038/s41591-023-02634-8}
}

RIS

TY  - JOUR
TI  - GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.
AU  - Leggio L
AU  - Hendershot CS
AU  - Farokhnia M
AU  - Fink-Jensen A
AU  - Klausen MK
AU  - Schacht JP
AU  - Simmons WK
PY  - 2023
JO  - Nature medicine
DO  - 10.1038/s41591-023-02634-8
UR  - https://doi.org/10.1038/s41591-023-02634-8
ER  - 

APA

L, L., CS, H., M, F., A, F., MK, K., JP, S., & WK, S. (2023). GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.. Nature medicine. https://doi.org/10.1038/s41591-023-02634-8

Source records